8-K: Newmark Group Settles Stockholder Derivative Lawsuit for $50 Million, Insurance-Funded

Newmark Group, Inc. has reached a $50 million settlement, funded by its directors and officers insurance carriers, to resolve a stockholder derivative lawsuit concerning a 2021 executive bonus and partnership unit redemptions.

Summary

• Newmark Group, Inc. (NMRK) announced an amended scheduling order for a hearing on a $50 million cash settlement to resolve a stockholder derivative litigation.
• The lawsuit, filed by plaintiffs Cardinal Capital Management, Robert Garfield, and Laborers Local No. 231 Pension Fund, alleged that a 2021 one-time cash bonus of $50 million to Executive Chairman Howard Lutnick and the redemption and exchange of 16.6 million partnership units for $146 million by certain officers were 'not entirely fair,' asserting causes of action for waste, unjust enrichment, and breach of fiduciary duty.
• The $50 million settlement will be funded exclusively by Newmark's directors and officers insurance carriers and paid to Newmark, the nominal defendant.
• The settlement agreement, dated February 7, 2025, is subject to approval by the Court of Chancery of the State of Delaware.
• The hearing on the Stipulation and Agreement of Compromise, Settlement, and Release has been rescheduled to August 13, 2025, at 11:30 a.m.
• Defendants, including Howard Lutnick, Barry Gosin, Michael Rispoli, Virginia Bauer, Michael Snow, and Kenneth McIntyre, denied any wrongdoing and entered into the settlement to avoid the 'delay, uncertainty and expense of protracted litigation.'
• The settlement includes a release of civil claims against the Board and executive officers related to the matter, with no admission of liability by the Board or other Defendants.
• Plaintiffs' counsel intends to apply for an award of attorneys' fees and expenses, and potentially an incentive award for plaintiffs, to be paid solely from the $50 million cash settlement amount.

Sentiment

Score: 7

Explanation: The settlement of a significant derivative lawsuit, funded by insurance, is a positive development as it removes a legal and financial overhang for Newmark. While the underlying issues that led to the lawsuit were negative, the resolution without direct company cash outflow and without admission of liability is a favorable outcome, contributing to increased certainty and stability.

Positives

• The resolution of a significant stockholder derivative litigation removes a cloud of uncertainty and potential ongoing legal expenses for Newmark.
• The $50 million cash settlement will be paid to Newmark, providing a financial benefit to the company.
• The settlement is funded exclusively by Newmark's directors and officers insurance carriers, meaning no direct cash outflow from Newmark's operating funds.
• The settlement avoids the 'delay, uncertainty and expense of protracted litigation,' allowing management to focus on core business operations.
• The settlement includes a release of civil claims against the Board and executive officers related to the matter, with no admission of liability by the Board or other Defendants.

Negatives

• The $50 million settlement amount will be reduced by Plaintiffs' counsel fees and expenses, and potentially an incentive award to Plaintiffs, before being paid to Newmark.
• The lawsuit stemmed from significant executive compensation decisions ($50 million bonus to Executive Chairman and $146 million in partnership unit redemptions) that led to allegations of unfairness and breach of fiduciary duty, highlighting past corporate governance concerns.
• The company and parties involved underwent extensive discovery, including the review of hundreds of thousands of documents and depositions, indicating a burdensome litigation process.

Risks

• The settlement is conditioned upon final approval by the Court of Chancery of the State of Delaware; if not approved, the Stipulation becomes null and void, and the litigation could resume.
• Forward-looking statements regarding the anticipated effects of the Settlement Agreement on the Company's business and financial results are subject to the risk that the actual impact may differ materially from current expectations.
• There is a potential for appeals or motions for reargument or rehearing following the Court's initial approval of the settlement, which could delay finality.

Future Outlook

The document contains forward-looking statements regarding the anticipated effects of the Settlement Agreement on Newmark's business and financial results. However, it explicitly states that the actual impact may differ, possibly materially, from what is currently expected, and Newmark undertakes no obligation to update these statements.

Management Comments

• "The Company and other Defendants entered into the Settlement Agreement to avoid the delay, uncertainty and expense of protracted litigation."

Industry Context

This settlement reflects a common outcome in corporate governance disputes within the financial services and commercial real estate sectors, where stockholder derivative lawsuits challenge executive compensation and related-party transactions. Such litigation, often resolved through D&O insurance, aims to provide a benefit to the company while allowing management to avoid the ongoing costs and distractions of prolonged legal battles, aligning with broader trends of increased shareholder activism and scrutiny over executive pay practices.

Comparison to Industry Standards

• The resolution of a significant derivative lawsuit for a substantial amount ($50 million) funded by Directors & Officers (D&O) insurance is a standard practice in corporate litigation, particularly for publicly traded companies facing allegations of fiduciary duty breaches related to executive compensation.
• This type of settlement allows the company (Newmark) to receive a financial benefit without directly impacting its operational cash flow, as the cost is borne by its insurers, which is a common and favorable outcome for the nominal defendant in such cases.
• While specific comparable companies or projects are not detailed in the filing, similar settlements have occurred across various industries where executive compensation or related-party dealings have been challenged, demonstrating a consistent approach to mitigating litigation risk and providing a recovery to the company on behalf of its shareholders.

Corporate Governance

Legal Proceedings

• Consolidated Derivative Litigation (C.A. No. 2022-0687-BWD) in the Court of Chancery of the State of Delaware, brought by stockholders on behalf of Newmark Group, Inc.
• The lawsuit alleged that a $50 million one-time bonus to Executive Chairman Howard Lutnick and the redemption/exchange of 16.6 million partnership units for $146 million by certain officers in 2021 were 'not entirely fair,' asserting claims of waste, unjust enrichment, and breach of fiduciary duty.
• The litigation involved extensive discovery, including the review of over 470,000 pages of documents and depositions of company officers.
• The parties have agreed to a proposed $50 million cash settlement, to be funded exclusively by Newmark's directors and officers insurance carriers and paid to Newmark.
• The settlement is subject to Court approval at a hearing scheduled for August 13, 2025, at 11:30 a.m.
• Upon final approval, the action will be dismissed with prejudice, and all related claims against the released parties will be fully and finally released, with no admission of liability by the defendants.

Related Party Transactions

• The lawsuit specifically concerned the '2021 Equity Event,' which involved the exchange of 16.6 million partnership units held by Newmark officers (Howard Lutnick, Barry Gosin, Michael Rispoli, and Stephen Merkel) for $146 million.
• Another key transaction at the center of the litigation was a one-time bonus award of $50 million to Newmark's Executive Chairman, Howard Lutnick.

Stakeholder Impact

• **Shareholders**: Indirectly benefit from the $50 million cash payment to Newmark (funded by insurance), which resolves a significant legal dispute and removes associated uncertainty, potentially improving investor confidence.
• **Management and Board of Directors**: Are released from civil claims related to the derivative litigation, with no admission of liability, reducing personal and professional exposure.
• **Insurance Carriers**: Are responsible for funding the $50 million settlement amount, fulfilling their obligations under the Directors & Officers (D&O) insurance policies.
• **Employees**: Benefit from the resolution of a major legal distraction, allowing the company to focus on its core business and strategic objectives.

Next Steps

• The Court will hold a Settlement Hearing on August 13, 2025, at 11:30 a.m., to determine whether to approve the proposed settlement.
• Newmark will post the Settlement Agreement and Amended Settlement Notice on its investor relations website (ir.nmrk.com).
• Newmark will file a Current Report on Form 8-K briefly describing the settlement and where stockholders can locate the documents.
• Newmark will mail the Settlement Notice to all record holders of Newmark stock and use reasonable efforts to notify beneficial owners.
• Newmark will file an affidavit with the Court regarding the dissemination of the Settlement Notice at least ten business days before the Settlement Hearing.
• Plaintiffs' Counsel will apply for an award of attorneys' fees and expenses, and potentially an incentive award for plaintiffs, from the Cash Settlement Amount.

Key Dates

Recommendation

Keywords

Newmark Group, NMRK, SEC filing, 8-K, derivative litigation, settlement, corporate governance, stockholder lawsuit, executive compensation, bonus, partnership units, Nasdaq transaction, eSpeed, financial services, real estate services